Article
Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.
Radiation research - 1 Feb 2013
Bunin Deborah I, Chang Polly Y, Doppalapudi Rupa S, Riccio Edward S, An Dahlia, Jarvis Erin E, Kullgren Birgitta, Abergel Rebecca J
Abstract excerpt
Two hydroxypyridinone-containing actinide decorporation agents, 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO), are being developed for the treatment of internal actinide contamination by chelation therapy. Dose-response efficacy profiles in mice were established for the removal of intravenously injec...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
